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Human lactoferrin (hLf) is a protein of the innate immune system which induces an apoptotic-like process in yeast. Determina-
tion of the susceptibility to lactoferrin of several yeast species under different metabolic conditions, respiratory activity, cyto-
plasmic ATP levels, and external medium acidificationmediated by glucose assays suggested plasmamembrane Pma1p (P3A-type
ATPase) as the hLf molecular target. The inhibition of plasmamembrane ATPase activity by hLf and the identification of Pma1p
as the hLf-binding membrane protein confirmed the previous physiological evidence. Consistent with this, cytoplasmic ATP
levels progressively increased in hLf-treated Candida albicans cells. However, oligomycin, a specific inhibitor of the mitochon-
drial F-type ATPase proton pump (mtATPase), abrogated the antifungal activity of hLf, indicating a crucial role for mtATPase in
the apoptotic process. We suggest that lactoferrin targeted plasmamembrane Pma1p H-ATPase, perturbing the cytoplasmic
ion homeostasis (i.e., cytoplasmic H accumulation and subsequent K efflux) and inducing a lethal mitochondrial dysfunction.
This initial event involved a normal mitochondrial ATP synthase activity responsible for both the ATP increment and subse-
quent hypothetical mitochondrial proton flooding process. We conclude that human lactoferrin inhibited Pma1p H-ATPase,
inducing an apoptotic-like process in metabolically active yeast. Involvement of mitochondrial H-ATPase (nonreverted) was
essential for the progress of this programmed cell death in which the ionic homeostasis perturbation seems to precede classical
nonionic apoptotic events.
Lactoferrin (Lf) is a 77-kDa iron-binding glycoprotein of thetransferrin family of proteins and an important effector mol-
ecule of innate immunity with antimicrobial activity in mamma-
lian mucosal fluids (reviewed in reference 1). We have previously
reported that human lactoferrin (hLf) induces apoptosis-like cell
death of the pathogenic opportunistic yeast pathogen Candida
albicans, demonstrating also that K channel-mediated K efflux
is a common apoptotic event in yeast and metazoan cells (2). At
present, the mechanism of action by which lactoferrin and other
antimicrobial peptides induce apoptosis-like processes in yeast
remains unknown (reviewed in reference 3). However, we have
previously identified in bacteria the proton-translocating ATPase
(H-ATPase) as the molecular target of lactoferrin, suggesting
that the subsequent perturbation of the proton gradient (pH)
and intracellular pH (pHi) will lead to cell death in vitro (4). This
finding revealed lactoferrin as a natural extracellular inhibitor of
the proton translocation mediated by H-ATPases, suggesting
that the possible inhibition of a similar target also explains its
antifungal activity. In this hypothetical case, the antifungal effect
of lactoferrinmight be due to altered pH homeostasis, as reported
for bacteria (4).
In yeast, control of pHi is critical for cell survival and is regu-
lated through a concertedmovement of protons out of the cytosol
controlled by the P-type (i.e., Pma1p) andV-type (i.e., V-ATPase)
H-ATPase pumps (H-ATPases), themajor electrogenic pumps
at the cytoplasmic and vacuolar membranes, respectively (5).
Whereas Pma1p moves cytosolic protons out of the cell mem-
brane, V-ATPase transfers protons into the vacuolar lumen. The
pHi is essential to protein folding and function, and proton gra-
dients underlie the physiology of organelles such asmitochondria.
Moreover, pHi variations could be a trigger signal or constitute an
optimal intracellular environment for proliferation, dimorphic
switching, and virulence of pathogenic yeasts (5; reviewed in ref-
erence 6). Finally, pHi decrease is an early apoptotic event ob-
served in yeast and in the death receptor-mediated andmitochon-
drion-dependent apoptosis of higher eukaryotic cells (7, 8, 9;
reviewed in reference 10).
The plasma membrane protein Pma1p (P3A-type ATPase) is a
single catalytic polypeptide (100 kDa) that couples ATP hydro-
lysis to the expulsion of protons, generating an electrochemical
proton gradient necessary for nutrient uptake and cellular ion
balance (11, 12, 13, 14, 15, 16). This H-ATPase is a primary
contributor to pHi regulation and is crucial for cell survival, as
shown by the potent fungicidal activity of certain Pma1p inhibi-
tors. For example, the chemical drug omeprazole and some syn-
thetic peptides which efficiently inhibit C. albicans Pma1p were
proposed as new models to design more effective antifungal ther-
apies (17, 18, 19; reviewed in reference 20). Besides this sugges-
tion, H-ATPases have also emerged as potential therapeutic tar-
gets for treatments against bacterial infections. For example,
bedaquiline, which belongs to the diarylquinoline class of drugs
and efficiently inhibits the H-ATPase (F-type ATPase) ofMyco-
bacterium tuberculosis, has been approved for treatment of multi-
drug-resistant tuberculosis (21). Despite the fact that Pma1p has
Received 2 February 2016 Returned for modification 24 April 2016
Accepted 27 April 2016
Accepted manuscript posted online 2 May 2016
Citation Andrés MT, Acosta-Zaldívar M, Fierro JF. 2016. Antifungal mechanism of
action of lactoferrin: identification of H-ATPase (P3A-type) as a new apoptotic-
cell membrane receptor. Antimicrob Agents Chemother 60:4206–4216.
doi:10.1128/AAC.03130-15.
Address correspondence to José F. Fierro, jffierro@uniovi.es.
M.T.A. and M.A.-Z. contributed equally to this work.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
crossmark
4206 aac.asm.org July 2016 Volume 60 Number 7Antimicrobial Agents and Chemotherapy
 o
n
 February 13, 2017 by UO
V BIBLIO
TECA UNIVERSITARIA
http://aac.asm
.org/
D
ow
nloaded from
 
been validated as an antifungal molecular target, drugs based on
inhibiting thisH-ATPase, which is essential for yeast survival but
is not present in human cells, have not yet been developed (17, 19,
20). Accordingly, the study of the possible interaction of lactofer-
rin with Pma1p could provide insight into strategies of the innate
immunity for controlling pathogenic opportunists, which may be
useful as a model for drug discovery and development of new
therapeutic strategies. Moreover, the inhibition of fungal Pma1p
H-ATPase, using lactoferrin or other specific inhibitors, became
an attractive model to dissect apoptotic events in yeast.
In the present study, we have used classical cellular physiology
and molecular approaches to assess whether Pma1p could be the
molecular target of lactoferrin, thus representing the first cell sur-
face receptor able to induce an apoptosis-like process in fungi.We
also investigated intracellular mechanisms underlying this pro-
grammed cell death, which exhibit some apoptotic events sim-
ilar to those characterized previously in higher eukaryotic cells
(1, 7, 22).
MATERIALS AND METHODS
Materials. Recombinant human apo-lactoferrin was obtained from Ven-
tria Bioscience (Sacramento, CA) and Sigma (St. Louis, MO). Goat anti-
human lactoferrin biotinylated polyclonal antibody and mouse anti-
Pma1p monoclonal antibody were obtained from Bethyl Laboratories
(Montgomery, TX) and Acris Antibodies (Herford, Germany), respec-
tively. Goat anti-mouse IgG secondary biotinylated antibody and anti-
bovine serum albumin (BSA) antibody were purchased from Abnova Co.
(Taipei, Taiwan). The ATPase assay kit and PiBin resin were purchased
from Innova Biosciences (Cambridge, United Kingdom). The BacTiter-Glo
microbial cell viability assay kit was purchased from Promega (Madison,
WI). Annexin V-fluorescein isothiocyanate (FITC) was purchased from
Thermo Fisher Scientific (Eugene, OR). All chemicals, unless otherwise
noted, were supplied by Sigma-Aldrich. Nitrocellulose transfer mem-
brane (0.45 m) was obtained from Bio-Rad (Hercules, CA). Sab-
ouraud-2%dextrose broth (SDB)was purchased fromDifco Laboratories
(Detroit, MI).
Strains and growth conditions. C. albicans ATCC 10231, Candida
glabrata ATCC 2001, and Saccharomyces cerevisiae ATCC 7752 were rou-
tinely cultured in SDB for 16 to 20 h at 30°C and subcultured in SDB to
mid-logarithmic growth phase. When required, C. glabrata and S. cerevi-
siae were grown under aerobiosis or anaerobiosis conditions in the pres-
ence of 2% glycerol or 2% glucose, respectively. The growth of yeast
under strict anaerobic conditions (80% N2, 10% CO2, and 10% H2)
was performed in an anaerobic chamber (model 1024; Forma Scien-
tific, Marietta, OH).
Fungicidal activity. Fungicidal activity was tested as previously de-
scribed, except that Tris buffer (10 mM Tris-HCl, pH 7.4) was used (7).
Starved cells were obtained bymaintainingwashed cells for 18 h inTris
buffer in an anaerobic chamber to deplete their carbon reserves and the
oxygen present in the buffer. The killing assays with starved cells or with
cells grown under anaerobic conditions were also performed inside the
anaerobic chamber. All the media and buffers used in anaerobiosis were
previously placed in the anaerobic chamber for 24 h.
Oxygen consumptionmeasurement.Oxygen consumptionwasmea-
sured using a Clark-type electrode (dual digital-model 20; Rank Brothers
Ltd., Cambridge, United Kingdom) at 25°C. C. albicans cells were grown
tomid-logarithmic phase in SDB at 30°C, washed twice in Tris buffer, and
resuspended in the same buffer. The assays were performed in 1.5 ml of
Tris buffer at 25°C. Cell suspensions (5 106 cells/ml) were preincubated
for 15 min at 37°C with hLf (25 M) or piericidin A (32 M).
Isolation of respiration-deficient yeast cells. C. albicans cells defec-
tive in mitochondrial respiration were induced by growing the cells at
42°C to stationary phase in the presence of acriflavine (100 g/ml), as
described previously (23, 24). Aliquots of the culture were plated on glu-
cose-limited agar plates, and single colonies were transferred with sterile
toothpicks to glucose- and glycerol-limited agar plates, the latter strictly
supporting cellular respiration (24). After 3 days of incubation at 30°C,
these plates were examined for the presence of colonies able to grow solely
on glucose plates. The sensitive colonies (petitemutants) growing only on
the fermentable carbon source (glucose) were verified as respiration-de-
ficient mutants by testing their respiratory function with a Clark-type
electrode and by the method for the color-based identification of RD
mutants. For the color-based identification of respiration-deficient mu-
tants, C. albicans cells were grown on plates containing the indicator me-
dium [1.5 g KH2PO4, 1.5 g (NH4)2SO4, 1 g MgSO4 · H2O, 1.5 g peptone,
1.5 g yeast extract, 20 g glucose, 0.01 g eosinY, 0.01 g trypanblue, 15 g agar,
1 liter H2O] as described previously (24).
Glucose-dependent external acidification. A glucose-induced acid
extrusion assaywas performed as described byMonk et al. (25), with slight
modifications. Briefly, cultures of C. albicans cells were grown to mid-log
phase in SDBmedium and washed twice in 10mMTris-HCl, pH 8.0. The
cells were resuspended in 50mMKCl and stored for 18 h at 4°C to deplete
their carbon reserves. To determine the external acidification, the cells
were concentrated (107 cells/ml) in 50 mM KCl, and lactoferrin (25
M) or oligomycin (64 g/ml) was immediately added. Cells were incu-
bated for 15min at 30°C, and the pHwas adjusted to 6.7. Acidificationwas
initiated by addition of glucose (final concentration, 2.5 mM) to the cell
suspension (1ml), and the time course wasmonitored using a SevenMulti
S50-K pHmeter (Mettler-Toledo, Greifensee, Switzerland) with constant
stirring. To measure the extent of acidification of the external medium,
the assay was performed in the absence of lactoferrin or oligomycin (con-
trol).
Plasmamembrane isolation.Yeast plasmamembraneswere obtained
as described previously (26), with slight modifications. Briefly,C. albicans
cells were grown in SDB at 30°C with vigorous aeration and harvested by
centrifugation (3,500  g, 10 min, 4°C) in the late-log phase of growth.
The cell pellet was washed twice with distilled water, suspended in fresh
homogenization buffer (2.5 mM EDTA, 1 mM ethylene glycol tetraacetic
acid [EGTA], 2 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonyl
fluoride [PMSF], and 50 mM Tris-HCl, pH 7.5), and disrupted by two
passages at 19,500 lb/in2 through a French pressure cell (SLM Aminco,
Silver Spring, MD). Cell debris and unbroken cells were removed by cen-
trifugation (3,000  g, 10 min), and the supernatant was further centri-
fuged (14,000 g for 20min at 4°C) to obtain a clarified homogenate. The
homogenate was centrifuged at 105,000 g for 2 h at 4°C, and the result-
ing preparation (pellet) containing membrane fragments was resus-
pended in ice-cold membrane suspension buffer (1 mM EDTA, 1 mM
PMSF, 10 mM Tris-HCl, pH 7.5) and centrifuged a second time at
105,000 g for 2 h at 4°C. The samplewas resuspended in the samebuffer,
and protein concentration was determined before the sample was stored
at80°C.
Estimation of intracellular ATP concentration.Measurements of the
average intracellular ATP concentration were made using the BacTiter-Glo
microbial cell viability assay kit according to the manufacturer’s instruc-
tions. Briefly, cells were grown to mid-log phase in SDB at 30°C, washed
twice in 10 mM Tris-HCl (pH 7.4), and resuspended at 105 cells/ml. Ali-
quots (1 ml) were incubated (90 min) with lactoferrin (5 M) or oligo-
mycin (32 g/ml), and then 100 l of cell suspensions was collected at
various time points and immediately heat inactivated. Twenty-fivemicro-
liters of cell lysates was transferred into 96-well opaque white plates,
mixed with an equal volume of the BacTiter-Glo reagent, and incubated
for 15 min in the dark. The reagent uses luciferase to produce lumines-
cence in an ATP-dependent manner. The emitted luminescence was de-
tected by using a Varioskan flash multimode reader (Thermo Scientific,
Waltham, MA) and was expressed as relative luminescence units. A cali-
bration curvewas prepared for each experimentwithATP standards rang-
ing from 0.1 to 100 nM.
Measurement of ATPhydrolysis.ATPhydrolysis was determined us-
ing a colorimetric ATPase assay kit and PiBind resin according to the
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manufacturer’s recommendations. All enzyme assays were performed
with plasma membranes at a protein concentration of 40 g/ml with 2
mM ATP at 30°C and pH 6.5. The amount of inorganic phosphate (Pi)
released was calculated by spectrophotometry (A650). For all experiments,
calibrationwas performed using a standard range of Pi concentrations. To
eliminate possible contributions from acid phosphatase as well as mito-
chondrial and vacuolar ATPases, 0.2mM(NH4)2MoO4, 5mMNaN3, and
50mMKNO3were present in the assaymix. Residual activity represented
specific ATP hydrolysis by Pma1p, as it was more than 90% inhibited by 1
mM diethylstilbestrol (DES), an inhibitor of fungal Pma1p H-ATPase
(27). To determine the effect of lactoferrin on ATPase activity, the plasma
membranes were preincubated with the protein for 30 min in the assay
medium before initiating the reaction.
Far-Western blotting and immunodetection assays. Far-Western
blotting was used as described previously, with some modifications (28).
Briefly, cytoplasmicmembrane protein samples, hLf, andmolecular mass
markers were separated by electrophoresis on SDS-PAGE gels and then
electroblotted (100 V, 1 h, 4°C) to a nitrocellulose transfer membrane in a
wet transfer system (Bio-Rad, Hercules, CA). Electroblotting was per-
formed in transfer buffer (24 mM Tris-HCl, 190 mM glycine, 1.3 mM
SDS, and 20%methanol). Transfer efficiencies were checked, and protein
wells and molecular weight standards were marked with a soft pencil
directly on themembrane after Ponceau-S staining. Following removal of
Ponceau-S by rinsing (2) in TBS buffer (20 mM Tris-HCl, 130 mM
NaCl, pH 7.6), themembrane was blocked in TBS containing 5% (wt/vol)
BSA for 13 h at 4°C. Strips containing the transferred plasma membranes
then were incubated with hLf (1 mg/ml) using the same buffer as the
diluent (5% BSA in TBS). After 90 min, the membrane was carefully
washed twice with 0.1% (vol/vol) Tween 20 in TBS. It then was incubated
with the anti-hLf biotinylated antibody (1:1,000) for 1 h. The membrane
was subsequently washed twice more with TBS containing 0.1% Tween
20. In separated membrane strips, Pma1p H-ATPase was identified by
incubation (1 h) of the blotted membrane proteins with a monoclonal
anti-Pma1p antibody (1:1,000). Similarly, hLf alone was detected by in-
cubation of the corresponding strips with the anti-hLf biotinylated anti-
body. As a negative control, duplicate electroblotted plasma membrane
proteins were probed with BSA and detected with the anti-BSA antibody.
Secondary antibody incubation (1 h) was performed with IgG biotinyl-
ated antibody (1:1,000). The binding of biotinylated antibodies was visu-
alized by addition of streptavidin-horseradish peroxidase (HRP) polymer
conjugate (1:10,000 dilution) and 3,3=,5,5=-tetramethylbenzidine (TMB),
a chromogenic substrate.
MS-MRManalysis.The proteomic analysis was performed in the Pro-
teomics Unit (PRB2-ISCIII; ProteoRed) of Complutense University of
Madrid. The gel slices containing previously immunodetected hLf-bind-
ing protein were reduced, carbamidomethylated, and then digested with
trypsin as described previously (29). The multiple reaction monitoring
(MRM) method used to detect and confirm the presence of the Pma1p
protein was developed by performing in silico analysis to predict the re-
sulting trypsin-digested peptides and by using liquid chromatography-
tandem mass spectrometry (LC-MS/MS) of the trypsin-digested protein.
Skyline (v. 3.1) was used to predict and optimize collision energies for the
detection of each peptide. The resultant method was exported to Analyst
1.6 (SCIEX) mass spectrometer acquisition software.
For the MRM assay, analyses were performed on an LC-MS/MS sys-
tem, including an Eksigent nanoflow LC system coupled to a hybrid tri-
ple-quadrupole/ion trapmass spectrometer (QTRAP5500; AB Sciex, Fos-
ter City, CA) equipped with a nanoelectrospray interface operated in the
positive ion mode. The digested sample was directly loaded onto a
NanoLC trap set (C18, 3 m, 120 Å; 350 m by 0.5 mm; ChromXP) at 3
l/min. After 5 min, the peptides were separated using an Eksigent col-
umn (75 by 15 cm; ChromXP NanoLC column) at 300 nl/min. Peptides
were then electrosprayed into the QTRAP 5500, which was set to operate
in the MRM mode. Data acquired were analyzed with Skyline software,
and theMS/MS data were analyzed using ProteinPilot 5.0.1 (SCIEX) soft-
ware to identify the peptides against DataBase with the FASTA sequence
of the targeted protein. Peptide identifications were accepted if they could
be established at a greater than 95% confidence interval (P  0.05), and
then they were used to generate a spectral library to ensure consistency
between the transition and the sequences of peptide searched.
Test for apoptotic markers. Apoptotic markers, including annexin
V-FITC labeling and the terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling (TUNEL) test, were performed with yeast
cells after 2 h of hLf exposition as described previously (2).
Statistical analysis.Unless stated otherwise, all experimentswere con-
ducted in triplicate on separate occasions. Means and standard deviations
(SD) were calculated and the Student t test performed to determine the
significance of the data sets using the program GraphPad Prism v.6. A P
value of0.01 was considered significant.
RESULTS
The antifungal activity of hLf depends on the cells’ energy me-
tabolism. Previously, we have reported that the antimicrobial ef-
fect of lactoferrin involved an active cellular cooperation (4, 7). To
examine the influence of energy metabolism on the antifungal
effect of lactoferrin, we first performed killing assays in oxygenic
and anoxic conditions (Fig. 1A). In the absence of oxygen, C.
albicans cells (starved cells) were almost totally resistant (93% 	
7% cell survival) to different concentrations of lactoferrin (1.25,
2.5, and 5 M), unlike nonstarved cells exposed to this protein
under oxygenic conditions, which were susceptible in an hLf con-
centration-dependent way (68% 	 7%, 38% 	 4%, and 14% 	
6% cell survival). Increased resistance to lactoferrin under anoxic
versus oxygenic conditions was also observed using Candida
glabrata (88% 	 6%, 74% 	 8%, and 71% 	 9% versus 24% 	
4%, 17% 	 6%, and 4% 	 2% cell survival, respectively) and
Saccharomyces cerevisiae cells (100%, 96%	 4%, and 97%	 3%
versus 98% 	 2%, 52% 	 5%, and 36% 	 7% cell survival, re-
spectively).
A second approach was used to assess the influence of the fer-
mentative metabolism on the antifungal activity of lactoferrin. C.
albicans is a Crabtree-negative species, a definition based on the
observation that C. albicans and other yeast continue to respire in
the presence of glucose (23, 30, 31). In contrast, themitochondrial
respiration of Crabtree-positive fungi (e.g., C. glabrata and S.
cerevisiae) is repressed by fermentable substrates (32). The suscep-
tibility ofC. albicans cells to hLf was similar under respiratory and
fermentative conditions obtained with cells grown in the presence
of 2% glycerol (aerobiosis) or 2% glucose (anaerobic chamber),
respectively (Fig. 1B). The percentages of viable cells exposed to
1.25, 2.5, and 5 M hLf under fermentative conditions were
75%	 6%, 50%	 7%, and 12%	 7% versus 57%	 4%, 44%	
12%, and 18% 	 5% of cell viability from assays performed in
aerobiosis. In a similar way, Crabtree-positive yeasts performing
oxygen respiration or fermentation showed a similar susceptibil-
ity to lactoferrin. Figure 1B shows data obtained from hLf-treated
cells grown in the presence of a fermentation-inducing concentra-
tion of glucose as the sole carbon source (C. glabrata, 54%	 6%,
32%	 8%, and 12%	 6% cell survival; S. cerevisiae, 84%	 5%,
62% 	 3%, and 36% 	 8% cell survival) with respect to cells
grown in the presence of glycerol (C. glabrata, 30%	 5%, 22%	
8%, and 17%	 7% cell survival; S. cerevisiae, 100%	 2%, 44%	
7%, and 32%	 4% cell survival).
The glycolysis inhibitor 2-deoxy-D-glucose (2-DG)was used to
verify the dependence of hLf activity on the fermentative metab-
olism (Fig. 1B). C. albicans cells preincubated (30 min) with 10
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mM 2-DG were less susceptible to 1.25, 2.5, and 5 M lactoferrin
(75%	 6%, 81%	 9%, and 66%	 5% cell survival).
Programed cell death of hLf-treated cells was verified as previ-
ously described (2). After 2 h, samples of C. albicans cells incu-
bated with lactoferrin exhibited peripheral fluorescence (annexin
V-FITC) and TUNEL-positive phenotypes in 21% 	 5% and
48% 	 7% of the cells, respectively (data not shown). Less than
5% of lactoferrin-treated cells stained positively for propidium
iodide, indicating a nonsignificant disruption of cytoplasmic
membrane (data not shown).
Cellular respiration is not inhibited by lactoferrin. Oxygen
utilization data obtained from cell suspensions exposed to a can-
didacidal concentration of lactoferrin (25M) showed a percent-
age of consumption of oxygen similar to that of the untreated cells
(control) over aminimumof 30min (Fig. 2A). In positive-control
assays, cellular respirationwas inhibited by 32MpiericidinA, an
inhibitor of the NADH dehydrogenase (complex I) of the respira-
tory chain.
Lactoferrin activity depends on cellular respiration. Two ex-
perimental approaches were used to confirm whether the activity
of lactoferrin was dependent on respiratory cellular function.
First, the candidacidal effect of lactoferrin was tested using C.
albicans cells preincubated (15 min at 37°C) with 4 or 8Mpieri-
cidin A. The piericidin A-treated cells, exposed for 90 min to dif-
ferent hLf concentrations (2.5 and 5 M), were less susceptible to
this protein (Fig. 2B). For example, cells preincubated with 8 M
piericidin A were less susceptible to 5 M hLf (94% 	 5% cell
survival) than cells not treated with piericidin A (17% 	 4% cell
survival), which were used as a control (Fig. 2B). Second, the fun-
gicidal activity of lactoferrin was assessed using a respiration-de-
ficient (RD) mutant (Fig. 2C). Data from killing assays showed
that this mutant strain was more resistant to hLf (2.5 and 5 M)
than the wild-type strain (100% and 97%	 8% versus 29%	 9%
and 19%	 8% cell survival, respectively). The RD mutant strain
was obtained by acriflavine exposition, and its respiration-defi-
cient phenotype was demonstrated by (i) the absence of oxygen
consumption by cell suspensions measured using a biological
oxygen monitor (Fig. 2D), (ii) the deep-violet color of RD mu-
tant colonies grown on indicator medium (Fig. 2E), and (iii) the
absence of growth in medium containing glycerol as a nonfer-
mentable carbon source (Fig. 2F).
Mitochondrial H-ATPase is essential for the antifungal ac-
tivity of lactoferrin. Previous reports have demonstrated thatmi-
tochondria play an essential role in other apoptosis-like processes
of yeast, as occurs in higher eukaryotic cells (33, 34, 35). To deter-
mine the role of mitochondria in the hLf-induced apoptosis, mi-
tochondrial function was inhibited with different concentrations
(4, 8, 16, and 32 g/ml) of oligomycin, a specific inhibitor of
mitochondrial F1F0-ATPase (mtATPase), in the presence of lacto-
ferrin. Figure 3 shows that the preincubation (15 min) of C. albi-
cans cells with oligomycin (4 g/ml) markedly decreased the an-
tifungal activity of lactoferrin (1.25, 2.5, and 5 M). Inhibition
(72% 	 4% cell survival) was obtained in the presence of 5 M
hLf and oligomycin (4 g/ml), and similar percentages of inhibi-
tion were obtained with 8 to 32 g/ml oligomycin (data not
shown).
In yeast, vacuolar H-ATPase (V-type ATPase) contributes to
vacuolar and cytosolic pH control and is susceptible to the mac-
FIG 1 Influence of the energetic metabolism on the fungicidal activity of lactoferrin. (A) Viability of yeast cells (105 cells/ml) in Tris buffer incubated for 90min
at 37°Cwith three different concentrations of hLf under anoxic (white columns) and oxygenic (black columns) conditions. Assays under anoxic conditions were
performed with starved yeast cells. (B) Viability of yeast cells grown in the presence of 2% glucose (fermentation) (white columns) or 2% glycerol (respiration)
(black columns) incubated with hLf for 90 min at 37°C. C. albicans cells were incubated with the metabolic inhibitor 2-DG before the hLf exposition (dashed
columns). Aliquots were plated and colonies were counted after 24 h. The results are the means	 SD from duplicates of at least three independent experiments.
Statistical significance was assessed by Student’s t test. *, P 0.01.
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rolide antibiotic bafilomycin A1 (5). Bafilomycin A1 is a highly
specific inhibitor of V-ATPase at nanomolar concentrations, but
P-ATPases are also sensitive to micromolar concentrations (36).
Low concentrations of bafilomycin A1 (1, 10, and 100 nM) slightly
increased the candidacidal activity of lactoferrin. Figure 3 shows
the effect of the lowest drug concentration (1 nM) assayed in the
presence of lactoferrin. A similar increased killing effect was ob-
served with 10 and 100 nM bafilomycin A1 (data not shown).
Intracellular ATP concentration is increased in hLf-treated
cells. Intracellular ATP content was measured luminometrically
to determinewhether the cell death induced by hLf was an energy-
dependent process, as apparently suggested by the protective ef-
fect of oligomycin. Interestingly, C. albicans cells treated with 5
M hLf resulted in a time-dependent incremental change of the
ATP concentration, displaying a more than 6-fold increase (90
min) comparedwith control cells (Fig. 4). Oligomycin (32g/ml)
abrogated the increment of intracellular ATP induced by hLf, in-
dicating the mitochondrial origin of the ATP accumulated in the
hLf-treated cells. In parallel, the viability of hLf-treated cells de-
creased in a time-dependent way, showing a direct relationship
between the accumulation of ATP and the loss of cell viability (Fig.
4). In addition, the increase of ATP content in hLf-treated cells
indicated that hLf was unable to reach the mtATPase of complete
cells.
Lactoferrin interacts with Pma1p H-ATPase. The data ob-
tained with C. albicans cells indicated that neither mitochondrial
nor vacuolar H-ATPases of complete cells were inhibited by lac-
toferrin. Consequently, we assumed that plasma membrane H-
ATPase is the molecular target of lactoferrin, and different assays
were performed with C. albicans cells and isolated plasma mem-
branes to assess this assumption.
FIG 2 Effect of cellular respiration on the candidacidal activity of lactoferrin. (A) Consumption of oxygen in C. albicans cells. Black, control cells; orange, cells
incubated with 32Mpiericidin A; red, cells treated with 25MhLf. The respiration inhibitor piericidin A was added 15min before the addition of lactoferrin.
(B) Viability ofC. albicans cells treated with different concentrations of hLf (black) or preincubated with 4M(brown) or 8M(orange) piericidin A before the
addition of hLf. (C) Susceptibility to hLf of wild-type (black) and respiration-deficient mutant (RDmutant) cells (purple). (D) Comparison of percentage of O2
consumption by wild-type (black) and RD mutant (purple) strains. (E) Color differentiation of wild-type (wt) and RD mutant strains on an indicator plate
containing eosin and trypan blue. On this medium, metabolically active wild-type cells were grown as pale-bluish colonies, while the RD mutant strains were
grown as deep-violet colonies. (F) Growth characteristics of wild-type (wt) and RDmutant strains on agar plates. Cells were incubated on glucose-limited agar
plates (upper) or on glycerol-limited agar plates (lower) for 72 h. The results are the means 	 SD from duplicates of at least three independent experiments.
Statistical significance was assessed by Student’s t test. *, P 0.01.
FIG 3 Influence of mitochondrial and vacuolar H-ATPases on candidacidal
activity of lactoferrin. Viability of C. albicans cells (105 cells/ml) treated with
different concentrations of hLf (red) for 90min at 37°C or preincubated for 15
min with 4 g/ml oligomycin (Oli; blue) or 1 nM bafilomycin A1 (Baf; ma-
genta) before the addition of hLf. Aliquots were plated and colonies were
counted after 24 h. The results are the means	 SD from duplicates of at least
three independent experiments.
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(i) Lactoferrin inhibits the glucose-induced acidification of
external medium. To test whether lactoferrin interacts with the
plasma membrane Pma1p H-ATPase of C. albicans cells, the
effect of this protein on the glucose-stimulated acidification of
unbuffered medium (50 mM KCl) was monitored. In Candida
cells depleted of their carbon sources, the addition of glucose in-
duces a proton-carbohydrate symport driven by the proton mo-
tive force (PMF). The PMF is generated by the proton gradient
maintained by the Pma1p H-ATPase, which couples the hydro-
lysis of ATP to the outward translocation of protons. The extru-
sion of protons that previously had entered the cytosolic com-
partment together with the glucose is the main cause of the
external acidification and can be measured with a pH electrode
(15, 18, 25, 37).
Figure 5 shows that the addition of glucose to glucose-starved
cell suspensions caused a rapid fall (1.37 	 0.07 pH units in 15
min) in the external pH (control assay). However, a significant
inhibition (0.14 pH 	 0.04 pH units in 15 min) of glucose-in-
duced acidification was observed in cell suspensions treated with
25 M lactoferrin. As expected, oligomycin (64 g/ml) had no
influence on the external acidification promoted by the presence
of glucose (Fig. 5). Under these experimental conditions (50 mM
KCl), cell viability was unaltered by hLf (data not shown), as pre-
viously reported (7). In these assays and before the addition of
glucose, a slow cellular H influx was manifested by a slow in-
crease in medium pH. The addition of lactoferrin did not change
the rate of this influx, excluding the possibility that lactoferrin
increased the passive permeability of cell membranes to protons
(data not shown). This observation agrees with our previous re-
ports showing that lactoferrin is unable to permeabilize the cell
plasma membrane (7). It was assumed that the cells used in these
assays were efficiently starved of glucose because they showed no
basal medium acidification properties but rapidly acidified the
medium following addition of glucose, as previously described
(25).
This result strongly suggested an inhibition of the plasma
membrane Pma1p H-ATPase by lactoferrin.
(ii) Inhibition of the plasma membrane ATPase activity by
lactoferrin. To determine the possible interaction of lactoferrin
with Pma1p H-ATPase, ATP hydrolysis catalyzed by the mem-
brane fraction of C. albicans cells in the presence or the absence of
lactoferrin was investigated. In the presence of vacuolar and mi-
tochondrial ATPase inhibitors, plasma membrane preparations
were preincubated with lactoferrin or left untreated, and the
amounts of inorganic phosphate (Pi) released were quantified. In
the absence of lactoferrin (control), residual activity [1.73	 0.27
mol Pi min
1 (mg protein)1, n
 3] represented specific ATP
hydrolysis by the Pma1p H-ATPase, as it was more than 90%
inhibited by 1mMdiethylstilbestrol (DES). Table 1 shows that the
ATPase activity was progressively inhibited when plasma mem-
brane samples were preincubated with increasing lactoferrin con-
centrations before initiating the reactionwithATP. The initial rate
of ATPase activity significantly decreased to 44.5%, 36.9%, and
31.7% in the presence of 5, 10, and 25Mlactoferrin, respectively.
(iii) Identification of the lactoferrin binding protein as
Pma1p H-ATPase. To identify the lactoferrin-binding pro-
tein(s), cytoplasmic membrane preparations were submitted to
far-Western blot analysis.
FIG 4 Kinetics of intracellular ATP content and viability of hLf-treated cells.
Measurement of intracellular ATP levels of cells of C. albicans resuspended in
Tris buffer incubated for 90 min at 37°C (black; control) or incubated with 5
M hLf (continuous red line), 32 g/ml oligomycin (purple), an inhibitor of
mitochondrial F1F0-ATPase (mtATPase), or oligomycin and lactoferrin (con-
tinuous blue line). Cell viability of the cell suspensions treated with hLf in the
absence (dashed red line) or in the presence (dashed blue line) of oligomycin
was determined using a plate count method as described in Materials and
Methods. Data are the means (	SD) from at least three experiments.
FIG 5 Effect of lactoferrin on glucose-dependent external acidification. The
proton pumping activity ofC. albicanswas determined bymonitoring glucose-
induced acidification of the external medium by measuring the pH by means
of an electrode as described in Materials andMethods. Starved cells (107 cells/
ml) resuspended in 50 mM KCl were preincubated with 25 M lactoferrin
(red) or 64 g/ml oligomycin (blue) for 15 min. Glucose (final concentration
of 2.5mM) thenwas added to induce the proton effluxmediated by the Pma1p
H-ATPase, as indicated by the external acidification. The glucose-induced
acidification of the external mediumwithout hLf or oligomycin wasmeasured
in control experiments (black line).Only themeandata (n
 3) are shown, and
the bars representing	 standard errors (coefficient of variation of10%) are
omitted for clarity.
TABLE 1 Effect of lactoferrin on plasma membrane ATPase activity
Treatment ATPase activitya (%)
Control 1.73	 0.27 (100)
DES (1 mM) 0.15	 0.03* (8.6)
Lactoferrin
5 M 0.77	 0.02* (44.5)
10 M 0.64	 0.04* (36.9)
25 M 0.55	 0.07* (31.7)
a ATPase activity of isolated plasma membranes expressed as mol Pi min
1 (mg
protein)1. Values in parentheses are percentages of activity with respect to the control.
ATPase activity in the presence or absence of lactoferrin was assayed in a buffer
containing 0.2 mM (NH4)2MoO4, 5 mM NaN3, and 50 mM KNO3 to inhibit acid
phosphatase and mitochondrial and vacuolar ATPases, respectively. Residual activity
represents specific ATP hydrolysis by the Pma1p H-ATPase, as it was more than 90%
inhibited by 1 mM diethylstilbestrol (DES). Values are means	 SDs from at least three
experiments. *, P 0.01.
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Human lactoferrin and cytoplasmic membrane proteins were
resolved by gel electrophoresis and transferred to a nitrocellulose
membrane. This membrane was cut into three strips (Fig. 6), cor-
responding to human lactoferrin (lane 1) and plasmamembranes
ofC. albicans cells (lanes 2 and 3).While all of the proteins blotted
to the nitrocellulose membrane were readily detected by Ponceau
staining, only an 100-kDa protein band was visualized in the
strip containing plasma membranes that were previously incu-
bated with hLf and detected with an anti-hLf biotinylated anti-
body (lane 2). A band with a similar molecular mass (100 kDa)
was immunodetected using themonoclonal anti-Pma1p antibody
in an independent strip (lane 3). Blotted lactoferrin (control) was
visualized as a unique 80-kDa stained band on a separate strip
(lane 1). This result strongly suggested that the identified hLf-
binding protein corresponded to Pma1p H-ATPase. Nonspe-
cific binding of the streptavidin-HRP polymer conjugate or BSA
was not detected in duplicate control blotted membrane proteins
(strips) probed only with the labeled streptavidin or with the anti-
BSA antibody. Lactoferrin binding to immobilized plasma mem-
brane protein was detected using an anti-human lactoferrin anti-
body and a secondary anti-hLf biotinylated antibody.
The identity of the100-kDa protein targeted by lactoferrin in
the immunodetection assays was determined by performing an
MRM-MS analysis. The MRM-MS methodology provides the
ability to rapidly search for candidate peptides obtained from the
mass fingerprints that match with the target of interest.
Twelve peptides, with parent and daughter ions, were included
in theMRMmethod. Nine of these possible peptides correspond-
ing to Pma1p were detected using a QTRAP 5500 mass spectrom-
eter, and six of them were confirmed by MS/MS sequence identi-
fication. Figure 6B shows the peptides detected and identified by
MRM-MS. Although two peptides typically are sufficient to con-
fidently identify a protein usingMRM-MS, six matching peptides
(70 amino acids) were conclusively obtained (P 0.05), indicat-
ing high confidence in the identity of the 100-kDa protein as
Pma1p H-ATPase (PMA1_CANAX; UniProt entry P28877).
DISCUSSION
In this study, we present data from a variety of cellular and mo-
lecular techniques supporting the idea that the plasmamembrane
Pma1p H-ATPase is targeted by human lactoferrin, inducing an
apoptotic-like process previously described in yeast (2). First, the
susceptibility to lactoferrin was tested using three yeast species
under differentmetabolic conditions to elucidatewhether the kill-
ing activity was an energy-dependent process or a disturbance of
the cellular ion homeostasis. The latter was reported in bacteria
where the blocking effect of lactoferrin on H-ATPase induced an
imbalance of the proton gradient and a lethal pHi perturbation (4).
Lactoferrin was active on three different species of yeast (C.
albicans, C. glabrata, and S. cerevisiae) under respiratory or fer-
mentative conditions but was almost inactive on starved cells. Un-
der aerobic conditions, the candidacidal effect of lactoferrin was a
respiratory-dependent process, as indicated by the decreased ac-
tivity of this protein in the presence of piericidin A, an inhibitor of
type I NADH dehydrogenase of Candida spp. Similarly, a respira-
tory-deficientmutant strain showed high resistance to lactoferrin.
These results indicated that mitochondrial respiration was an im-
portant function for the antifungal activity of lactoferrin, suggest-
ing a key role of these organelles in this apoptotic-like process, as
was previously observed in apoptotic higher eukaryotic cells (33,
35). However, the oxygen consumption of hLf-treated cells was
unmodified with respect to control cells, indicating that compo-
nents of the respiratory chain were not targeted by lactoferrin.
The antifungal activity was almost abolished using starved
cells, suggesting that the candidacidal effect of lactoferrin was an
energy-dependent process requiring ATP consumption. This was
supported by the fact that oligomycin, an inhibitor of mitochon-
drial F1F0-ATPase (mtATPase), and 2-deoxy-D-glucose (2-DG),
an inhibitor of the glycolytic pathway, mitigated the killing activ-
ity of lactoferrin on respiring and fermenting cells, respectively. In
contrast, the cytoplasmic ATP level of respiring C. albicans cells
incubated with lactoferrin progressively and significantly in-
FIG 6 Identification of the plasma membrane lactoferrin-binding protein of C. albicans. (A) Far-Western blot of interaction between lactoferrin and an
100-kDa protein. Partial SDS-PAGE images show the protein bands corresponding to the bands detected by far-Western blotting. Lane 1, human lactoferrin
(hLf). Lane 2, plasmamembrane (PM) proteins incubated with hLf. hLfb, hLf bound to an100-kDa protein. Lane 3, PM proteins incubated with anti-Pma1p.
Far-Western membranes were stripped and challenged with either anti-hLf biotinylated antibody (lanes 1 and 2) or mouse anti-Pma1p monoclonal antibody
(lane 3). The location of anti-Pma1p using a secondary antibody (IgG biotinylated antibody) is shown. Binding of biotinylated antibodies was visualized by
addition of streptavidin-HRP polymer conjugate and a chromogenic substrate. (B) Identification of the plasma membrane hLf-binding protein by LC-MS/MS
MRM. Nine trypsin peptides were detected by LC-MS/MS analysis corresponding to the C. albicans protein Pma1p (UniProt entry P28877; PMA1_CANAX).
MW, molecular weight; m/z, experimentally determined mass-to-charge ratio; dotp, dot product.
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creasedwith respect to the control, indicating that, as was found in
bacteria, the cidal activity of this protein was not an energy-con-
suming process but required an active cellular metabolism (7).
Furthermore, a similar increment of cytosolic ATP levels in apop-
tosis of higher eukaryotic cells was previously reported and was
even interpreted as a prerequisite for the progression of the apop-
totic process (38, 39). Previous reports suggested that partial in-
hibition of plasmamembrane Pma1pH-ATPase increasesmito-
chondrial F1F0-ATPase activity (40). Similarly, the increment of
synthesized ATP observed in hLf-treated yeast cells is in agree-
ment with those observations, suggesting the inhibition of the
Pma1p H-ATPase.
Taken together, all of the above-described observations were
compatible with an ion homeostasis disturbance mediated by an
active metabolism rather than an energy-dependent process.
Moreover, this idea was congruent with the previously reported
K efflux, pHi decrease, and observed changes of transmembrane
electrical potential () in hLf-treated C. albicans cells (2, 7, 22).
Since Pma1p H-ATPase is the main cellular component respon-
sible for the regulation of pHi and formaintenance in fungi, all
of the above-described results were again in accordance with the
possible involvement of this proton pump in the apoptotic-like
process induced by lactoferrin.
In bacteria, two representativemembers of the transferrin fam-
ily of proteins, lactoferrin and transferrin, target H-ATPase.
Consequently, the proton gradient and pHi are perturbed, leading
to cell death (4). Despite the structural differences between the
plasmamembrane H-ATPases of bacteria (F-type ATPases) and
fungi (P-type ATPases), they share an ancestral origin, and some
amino acid sequences have been conserved throughout evolution
(41). Therefore, we hypothesized that plasma membrane Pma1p
H-ATPase is a target for lactoferrin that is accessible on the cell
surface of C. albicans cells, and this assumption was assessed ex-
perimentally.
In yeast, themeasurement of the glucose-induced acidification
of the external medium is used for the determination of the activ-
ity of Pma1p H-ATPase of complete cells and to identify drugs
thatmay inhibit this proton pump (15, 18, 25, 37). In the presence
of lactoferrin, a clear inhibition of theH-ATPase-mediated acid-
ification of the external medium by C. albicans cells was observed,
supporting the hypothesis that Pma1p is the cellular target of this
protein. As expected, oligomycin alone was unable to inhibit the
extracellular glucose-induced acidification, a result which agreed
with the knownoligomycin resistance of fungal P-type andV-type
ATPases. This result suggested that oligomycin, which inhibited
the candidacidal activity of lactoferrin, and lactoferrin targeted
different types of H-ATPases. Moreover, the protector effect of
oligomycin on the candidacidal activity of lactoferrin again sup-
ported the idea that the mitochondrial F1F0-ATPase (mtATPase)
was involved in the apoptosis-like process triggered by lactoferrin.
Recently, we reported a similar involvement of mtATPase in the
apoptosis-like process induced by hLf of S. cerevisiae cells (42).
To validate the above-described physiological data supporting
Pma1p H-ATPase as the target of lactoferrin, evidence of the
ability of lactoferrin to interact with thisH-ATPasewas provided
by the inhibitory effect of this protein on the ATPase activity of
plasma membrane fractions of C. albicans cells. This interaction
also was suggested by immunodetection methods showing the
binding of lactoferrin to an 100-kDa protein. The electropho-
retic migration of this plasma membrane protein was similar to
that of Pma1p detected with a monoclonal antibody specific for
this H-ATPase. Finally, this protein was identified by MRM-MS
analysis as Pma1p, confirming the previous physiological evi-
dence. To the best of our knowledge, other natural proteins or
peptides with inhibitory activity on Pma1p H-ATPase have not
been described previously.
In mammalian and yeast cells, a causal relationship between
the F1F0-ATPase function and execution of the apoptotic mito-
chondrial cell death pathway has been previously demonstrated,
but the role of the mitochondrial F1F0-ATPase in this process
remains unclear (reviewed in reference 34). A reverse operation of
the F1F0-ATPase proton pump, effluxing protons, and consuming
ATP in apoptotic yeast cells expressing the mammalian proapop-
totic Bax protein has been hypothesized (8, 34, 35). However, in
our case, the progressive increase of the ATP content in hLf-
treated cells with respect to the control, which was abrogated by
oligomycin, suggested that mitochondrial F1F0-ATPase function
was not reverted. Interestingly, hLf-treated viable cells increased
in the presence of either oligomycin or piericidin A, showing a
correlation between mtATPase activity and candidacidal effect.
We interpret this result as a consequence of the ability of these
drugs to directly or indirectly interrupt the flow of protons via
mtATPase to the mitochondrial matrix.
More work needs to be done to elucidate the mechanism by
which yeast undergo apoptosis induced by Pma1p inhibition. In
order to integrate the present results with previously reported re-
sults (2, 7, 22), we propose a hypothetical mechanism for the apo-
ptosis-like process induced by lactoferrin (Fig. 7). Briefly, the in-
hibition of Pma1pH-ATPasewill cause two types of intracellular
events, including (i) cytoplasmic ionic events, where the accumu-
lation of cytoplasmic protons (7), consequence of an active me-
tabolism, and the subsequent pHi decrease will promote the K

channel-mediated K efflux and the membrane depolarization
previously reported (2, 7). In thismodel, cytoplasmic acidification
will be the first intracellular apoptotic event leading to (ii) the
mitochondrial ionic events, where the previous cytoplasmic K
efflux could facilitate the K efflux from the mitochondrial ma-
trix, for example, through the mitochondrial K/H antiporter
(43). This will facilitate the acidification of themitochondrial ma-
trix, because the mitochondrial effluxed K could be replaced by
massive H reentry via mtATPase (ATP synthase), establishing
two coupled cytoplasmic and mitochondrial K/H-positive
feedback loops. The supposed intramitochondrial acidification
(mitochondrial proton flooding) will be a second and critical trig-
gering signal leading to the subsequent nonionic steps of apop-
totic cell death. Evidence implicating the dysregulation of cellular
pH as an early event for the induction of apoptosis involving mi-
tochondria has been reported (reviewed in reference 8).
Under our experimental conditions, the cell is unable to use
alternative mechanisms for proton homeostasis. Consequently,
the inability to extrude protons across Pma1pH-ATPase leads to
cytoplasmic acidification, which will be the first triggering signal
of apoptosis induced by lactoferrin. Accordingly, the increased
candidacidal activity of lactoferrin in the presence of bafilomycin
A1, an inhibitor of the vacuolar H
-ATPase (V-type ATPase),
could be due to the additional cytoplasmic accumulation of pro-
tons which were not pumped to the vacuole of bafilomycin-
treated cells, leading to an acceleration of the cell death process.
Lactoferrin seems to interact specifically with at least two dif-
ferent protonpumpclasses (F- andP-typeATPases) of theATPase
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family (4). Therefore, the presence of a common structural motif
in these ATPases with affinity for a specific region of lactoferrin
can be postulated. This suggestion implies the existence in lacto-
ferrin, and probably other relatedmembers of the transferrin fam-
ily of proteins, of a complementary structurewhichwould interact
with the predictedmotif ofH-ATPases. Supporting this, we have
previously identified a structural domain in lactoferrin that could
interact with the postulated H-ATPase-interacting region (44,
45, 46). This hLf region, when synthesized as a peptide (hLf Uni-
Prot entry P02788171-201; kaliocin-1), retained the antimicro-
bial activity of lactoferrin under similar experimental conditions
(45). Indeed, kaliocin-1 exhibited high identity and homology to
the antimicrobial multidimensional signature named gamma-
core (-core), an evolutionarily well-conserved structural motif
found in all natural antimicrobial Cys peptides (46, 47). More-
over, the -core motif of lactoferrin also includes the Rana box
and CXGmotifs previously identified in other natural antimicro-
bial peptides, adding support to this structure being a candidate
for the interaction of lactoferrin with H-ATPases (45). Studies
are in progress to identify this putative receptor region of the
ATPase family and to verify the hypothesis that the identified
-core motif is the complementary lactoferrin-ligand region.
The induction of fungal apoptosis by different external induc-
ers (i.e., peptides and chemical-apoptotic triggers) have been re-
ported, but the intracellularmechanisms have not been elucidated
(reviewed in references 3 and 48). To our knowledge, the plasma
FIG 7 Schematic diagram illustrating themechanism by which lactoferrin hypothetically induces an apoptosis-like process in yeast. Previously reported data on
hLf-induced cell death have been incorporated into this model (2, 7, 22). InC. albicans cells, proton pumping through the Pma1pH-ATPase (a) is essential for
generation of a proton gradient (pH) across the cytoplasmicmembrane (CM) and for pHhomeostasis, which is critical for cell survival.Under our experimental
conditions, the blocking effect of hLf on Pma1p H-ATPase (b) seems to induce a lethal perturbation in ionic homeostasis in two hypothetical coupled phases.
Phase 1 is cytoplasmic ionic events, such as the intracellular accumulation of protons generated by an active metabolism due to the blocking effect of hLf on
Pma1p H-ATPase. To balance the electrical charge, accumulated protons pull potassium ions outside the cell through K channels. These previously reported
ion-mediated events (2, 7, 22) will lead to phase 2, mitochondrial ionic events, where the previous cytoplasmic K efflux could facilitate a loss of mitochondrial
potassium ions and the simultaneous reemplacement of mitochondrial potassium ions by protons entering via mtATPase, as suggested by incremental ATP
synthesis. The coupled cytoplasmic and mitochondrial K/H loops are indicated by the black and red thick arrows, respectively. Supporting this hypothesis,
cellular protection was observed when the accumulation of protons in the mitochondrial matrix via mtATPase was prevented by (i) inhibition of the mtATPase
with oligomycin and (ii) inhibition of proton translocation mediated by the respiratory chain, as suggested by the results obtained using piericidin A, anoxic
conditions, or a respiration-deficient mutant. The hypothetical mitochondrial proton flooding process mediated by mtATPase could trigger the subsequent
nonionic apoptotic events.
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membrane Pma1p H-ATPase is the first cell membrane apop-
totic receptor identified in yeast. The hLf-induced programmed
cell death shows striking similarities to the intrinsicmitochondrial
apoptosis type (intrinsic pathway) described for higher eukaryotic
cells due tomtATPase being essential for progression to cell death
(34). These results illustrate the potential application of lactofer-
rin and other selective Pma1pH-ATPase inhibitors asmolecular
tools to gain insight into fungal apoptotic-intracellular events.
Furthermore, the identification of the fungal target of lactoferrin
confirms previous proposals of Pma1pH-ATPase as an antifun-
gal target of therapeutic interest (19, 20) and may improve our
knowledge on the defensive role of this effectormolecule of innate
immunity in the context of host-parasite interactions.
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